IL1R2 promotes tumor progression via JAK2/STAT3 pathway in human clear cell renal cell carcinoma

Y Liu, Z Xing, M Yuan, B Xu, L Chen, D Zhang… - … -Research and Practice, 2022 - Elsevier
Clear cell renal cell carcinoma (ccRCC) is known as the most aggressive subtype of
genitourinary cancers. The lack of effective therapies has prompted us to further explore the …

[HTML][HTML] Expression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma

Y Chang, L Xu, H An, Q Fu, L Chen… - International journal of …, 2015 - ncbi.nlm.nih.gov
Abstract Interleukin-4 (IL-4) and IL-13 are anti-inflammatory and immunoregulatory cytokines
that can influence cancer-directed immunosurveillance. However, they are not evaluated as …

[HTML][HTML] Development and validation of an IL6/JAK/STAT3-related gene signature to predict overall survival in clear cell renal cell carcinoma

C Zhan, C Xu, J Chen, C Shen, J Li, Z Wang… - Frontiers in Cell and …, 2021 - frontiersin.org
Background: Traditional clinicopathological features (TNM, pathology grade) are often
insufficient in predictive prognosis accuracy of clear cell renal cell carcinoma (ccRCC). The …

Interleukin4Rα (IL4Rα) and IL13Rα1 are associated with the progress of renal cell carcinoma through janus kinase 2 (JAK2)/forkhead box O3 (FOXO3) pathways

MA Kang, J Lee, SH Ha, CM Lee, KM Kim, KY Jang… - Cancers, 2019 - mdpi.com
Specific kinds of interleukin (IL) receptors are known to mediate lymphocyte proliferation and
survival. However, recent reports have suggested that the high expression of IL4Rα and …

Identification of IRF-associated molecular subtypes in clear cell renal cell carcinoma to characterize immunological characteristics and guide therapy

C Chen, LY Chen, RX Yang, JX Zhang, PF Shao… - Frontiers in …, 2023 - frontiersin.org
Recently studies have identified a critical role for interferon regulatory factor (IRF) in
modulating tumour immune microenvironment (TME) infiltration and tumorigenesis. Based …

Overexpression of IRF3 predicts poor prognosis in clear cell renal cell carcinoma

J Wu, X Leng, Z Pan, L Xu, H Zhang - International Journal of …, 2021 - Taylor & Francis
Background Growing findings have demonstrated that interferon regulatory transcription
factor (IRF) family members are linked to the progression of various cancers. However, the …

Identification of IL20RB as a novel prognostic and therapeutic biomarker in clear cell renal cell carcinoma

H Guo, S Jiang, H Sun, B Shi, Y Li, N Zhou… - Disease …, 2022 - Wiley Online Library
Background. Clear cell renal cell carcinoma (ccRCC) is a type of life‐threatening malignant
tumor of the urinary system. IL20RB, interleukin 20 receptor subunit beta, is a cytokine …

JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma

F Liang, Z Li, P Huang - International immunopharmacology, 2020 - Elsevier
Kidney renal clear cell carcinoma (KIRC) is one of the most common cancers globally, with
an overall poor prognosis. The Janus kinase (JAK) family plays an essential role in cellular …

The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth

Y Su, A Zhao, G Cheng, J Xu, E Ji… - Cancer Biomarkers, 2017 - content.iospress.com
BACKGROUND: Renal cell carcinoma (RCC) is the highest mortality rate of the
genitourinary cancers, and the treatment options are very limited. Thus, identification of …

[HTML][HTML] MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis

H Xiao, J Zeng, H Li, K Chen, G Yu, J Hu, K Tang… - Oncotarget, 2015 - ncbi.nlm.nih.gov
MicroRNAs (miRNA) that are strongly implicated in carcinogenesis have recently reshaped
our understanding of the role of noncoding RNAs. Here, we focused on the function and …